Actively Recruiting
Myeloproliferative Neoplastic Diseases Observatory From Brest
Led by University Hospital, Brest · Updated on 2024-08-12
1000
Participants Needed
1
Research Sites
526 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
All patients diagnosed or followed in Brest University Hospital for Philadelphia negative myeloproliferative neoplasms will be included in this observational study. Myeloproliferative neoplasms recorded included: polycythemia vera, essential Thrombocythemia and Primary Myelofibrosis. This is a not interventional study. Alive patients need to sign a non-opposition consent form. Patients will be followed until last news (death, change of reference centre...).
CONDITIONS
Official Title
Myeloproliferative Neoplastic Diseases Observatory From Brest
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with essential thrombocythemia, polycythemia vera, or primary myelofibrosis
- Signed non-opposition consent form
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHRU de Brest
Brest, France, 29609
Actively Recruiting
Research Team
J
Jean-Christophe Ianotto
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here